(Press-News.org) Writing in the journal Nature Communications, a collaboration between the Universities of Manchester and Cambridge, which includes Nobel Prize winning scientists Professor Andre Geim and Professor Kostya Novoselov, has discovered a crucial recipe for improving characteristics of graphene devices for use as photodetectors in future high-speed optical communications.
By combining graphene with metallic nanostructures, they show a twentyfold enhancement in harvesting light by graphene, which paves the way for advances in high-speed internet and other communications.
By putting two closely-spaced metallic wires on top of graphene and shining light on this structure, researchers previously showed that this generates electric power. This simple device presents an elementary solar cell.
More importantly for applications, such graphene devices can be incredibly fast, tens and potentially hundred times faster than communication rates in the fastest internet cables, which is due to the unique nature of electrons in graphene, their high mobility and high velocity.
The major stumbling block towards practical applications for these otherwise very promising devices has so far been their low efficiency. The problem is that graphene – the thinnest material in the world – absorbs little light, approximately only 3%, with the rest going through without contributing to the electrical power.
The Manchester researchers have solved the problems by combining graphene with tiny metallic structures, specially arranged on top of graphene.
These so-called plasmonic nanostructures have dramatically enhanced the optical electric field felt by graphene and effectively concentrated light within the one-atom-thick carbon layer.
By using the plasmonic enhancement, the light-harvesting performance of graphene was boosted by twenty times, without sacrificing any of its speed. The future efficiency can be improved even further.
Dr Alexander Grigorenko, an expert in plasmonics and a leading member of the team, said: "Graphene seems a natural companion for plasmonics. We expected that plasmonic nanostructures could improve the efficiency of graphene-based devices but it has come as a pleasant surprise that the improvements can be so dramatic."
Professor Novoselov added: "The technology of graphene production matures day-by-day, which has an immediate impact both on the type of exciting physics which we find in this material, and on the feasibility and the range of possible applications.
"Many leading electronics companies consider graphene for the next generation of devices. This work certainly boosts graphene's chances even further."
Professor Andrea Ferrari, from the Cambridge Engineering Department, who lead the Cambridge effort in the collaboration, said "So far, the main focus of graphene research has been on fundamental physics and electronic devices.
"These results show its great potential in the fields of photonics and optoelectronics, where the combination of its unique optical and electronic properties with plasmonic nanostructures, can be fully exploited, even in the absence of a bandgap, in a variety of useful devices, such as solar cells and photodetectors"
Graphene is a novel two-dimensional material which can be seen as a monolayer of carbon atoms arranged in a hexagonal lattice.
It is a wonder material that possesses a large number of unique properties and is currently considered in many new technologies.
The world's thinnest material was discovered at The University of Manchester in 2004, which was acknowledged by the 2010 Nobel Prize in Physics awarded to Geim and Novoselov for their "groundbreaking experiments regarding the two-dimensional material graphene".
INFORMATION: END
The US economy continues to produce conflicting headlines and consumer anxiety on a daily basis as unemployment remains above 9 percent. Those looking for a short-term financial solution routinely turn to online lending resources such as Personal Cash Advance, which promotes best loan options such as secure cash advances, payday loans, and other personal loans.
"Our new guide to finding the best loans has been met with much enthusiasm from consumers as the economy continues to heal," PersonalCashAdvance.com company spokesperson Neil Cutting said. "As a ...
"Our data indicate that the brain becomes hypersensitive to rewards when this co-signaling of glutamate and dopamine does not function. Lower doses than normal are enough to increase the propensity to ingest the substance, and this is true of both sugar and cocaine," says Åsa Mackenzie, associate professor of neuroscience at Uppsala University and the researcher who led the study.
Addiction disorders are a major social problem, and we lack sufficient knowledge of how they arise and how various substances impact the brain. The brain's reward system gives us feelings of ...
Since 2007 Transcatheter Aortic Valve Implantation (TAVI) has become an alternative treatment for elderly patients with severe aortic stenosis at high risk for surgical aortic valve replacement. At present, durability and hemodynamic performance of transcatheter aortic valves remain unclear. Our single center data of the German Heart Center in Munich demonstrates a sustained improvement of hemodynamic performance up to 3 years after CoreValve implantation.
Aortic valve stenosis (AS) is the most frequent heart valve disease in Europe and North America. The most common ...
Primary PCI is the best reperfusion therapy for patients presenting with acute ST-elevation myocardial infarction. CJ Terkelsen and co-workers used the Western Denmark Heart Registry to describe the implementation of primary PCI in Denmark. Their study (including almost 10,000 patients) showed that a strategy with early diagnosis based on ECG recording in the ambulance and directing the patients straight to the catherization laboratory in the Primary PCI Centre, was associated with a lower mortality.
Direct access to PPCI is unfortunately still not possible in many European ...
Results from the SCAAR study, presented at the ESC Congress 2011 today, showed that Percutaneous Coronary Intervention (PCI) with "new generation" Drug Eluting Stents, was associated with a 38% lower risk of clinically meaningful restenosis and a 50% lower risk of stent thrombosis compared to old generation DES.
Although many trials and studies support the overall early and mid-term safety and efficacy of first-generation drug-eluting stents, there has been concern on their long-term safety, especially regarding the potential risk of late stent thrombosis as well as ...
With a great response from the audience Christopher Flach's film Madeleine Castaing, ended the last days of the Cesis Festival along with the final concert "Imants Kalnins and Philip Glass." Attended by more than 1800 visitors, this years 2011Festival contained a rich program featuring a diverse range of art forms included classical music concerts, visual art exhibitions, films and drama performances.
Christopher Flach's film "Madeleine Castaing," is the documentary that explores the personality and influence of the French decorator and antique dealer. ...
Acute myocardial Infarction (AMI) is a major cause of death and disability. Worldwide, one in eight patients die of an ischemic heart disease. Its rapid and accurate diagnosis is critical for the initiation of effective evidence based medical management, including early revascularization, but is still an unmet clinical need. The gradual implementation of high-sensitive cardiac troponins (hs-cTnT) in clinical practice has helped clinicians to detect and treat patients with acute myocardial infarction earlier than with conventional assays. But, high-sensitive assays have ...
Compared to patients who had persistently high platelet reactivity, those who achieved low platelet reactivity, according to the VerifyNow P2Y12 Test, had a reduced incidence of cardiovascular death, heart attack and stent thrombosis, as indicated by a clinical trial presented today at the ESC Congress 2011.
These findings were part of a secondary analysis of the Gauging Responsiveness with A VerifyNow P2Y12 Assay- Impact on Thrombosis and Safety (GRAVITAS) trial, the largest prospective trial to date to test the clinical efficacy of antiplatelet therapy modification, ...
Although medication which decreases the risk of angina attacks (chest pain caused by blockage of the arteries that supply the heart), are frequently prescribed in patients who have sustained a myocardial infarction, the possible influence of medication on long-term survival is not known, with the exception of beta-blocking agents, which have been shown to decrease mortality in clinical trials performed 30 years ago. Because antianginal drugs also protect the myocardium against ischemia (insufficient oxygen delivery to the heart muscle), there is a possibility that they ...
Results from a study presented today at the ESC Congress 2011, show that TAVI implantation in low risk patients, met with 100% procedural success (versus 95.3% in the high Euroscore group (p=0.1).
"The most interesting point to observe is the absence of death at one month in the low Euroscore group, versus a mortality rate of 11.1% in the high Euroscore group (>20%), (p < 0.04) and this result is confirmed at 1-year with 5 vs 24.8 %, (p END ...
